newsfilter
← Latest News
GlobeNewswire·

Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat

- Matthew Gall appointed Chief Financial Officer -- Additional key appointments add expertise in clinical operations, corporate strategy and project leadership - BOSTON, April 15, 2026 (GLOBE NEWSWIRE) -- Tango